Back
HFA Premium Access

Introducing SGLT2 inhibitors during hospitalization. Safety and outocmes.

Session: Poster session 1 - Basic Science - Chronic Heart Failure – Treatment
Topic: Pharmacotherapy
Speaker: Doctor F. Camacho Jurado (Puerto Real, ES)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Francisco Javier Camacho Jurado

Puerto Real Hospital, Puerto Real (Spain)
0 follower

13 more presentations in this session

Elamipretide restores protein and mRNA expression levels of S100A1 in left ventricular myocardium of dogs with chronic heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Access
Abstract
Like
Thumbnail

Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats

Speaker: Miss M. Krasnova (Saint Petersburg, RU)

Access
Abstract
Slides
Like
Thumbnail

Outcome evaluation of the association of sacubitril/valsartan and iSGLT2 in diabetic patients with heart failure with reduced ejection fraction.

Speaker: Doctor F. Camacho Jurado (Puerto Real, ES)

Access
Abstract
Like
Thumbnail

Outcome evaluation of Sacubitril/Valsartan in patients with Heart Failure and reduced ejection fraction with regular follow-up meetings in a Spanish heart failure day-hospital.

Speaker: Doctor F. Camacho Jurado (Puerto Real, ES)

Access
Abstract
Like
Thumbnail

Effects of irbesartan for renal failure in the patients with chronic heart failure and preserved systolic function and atrial fibrillation

Access
Like
Thumbnail

Access the full session

Poster session 1 - Basic Science - Chronic Heart Failure – Treatment

Speakers: Doctor F. Camacho Jurado, Professor H. Sabbah, Miss M. Krasnova, Doctor F. Camacho Jurado, Doctor F. Camacho Jurado
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources